Ocular Therapeutix, Inc. (OCUL)
Ocular Therapeutix, Inc. (OCUL) Insider Trading
Directors, officers and holders of more than 10% of OCUL report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 133 transactions on file: 1 with code P, 24 with code S and 25 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | Anderman Todd | Chief Legal Officer | S Sale | 11,984 | $7.29 | $87,363 |
| Oct 2, 2026 | Heier Jeffrey S. | Chief Scientific Officer | S Sale | 10,869 | $7.05 | $76,626 |
| Oct 2, 2026 | Kaiser Peter | Chief Development Officer | S Sale | 9,990 | $7.05 | $70,430 |
| Aug 31, 2026 | Notman Donald | Chief Operating Officer | S Sale | 1,099 | $10.24 | $11,254 |
| Aug 25, 2026 | Dugel Pravin | See Remarks | G Gift | 50,092 | Not measured | Not measured |
| Aug 25, 2026 | Dugel Pravin | See Remarks | G Gift | 50,092 | Not measured | Not measured |
| Aug 24, 2026 | Dugel Pravin | See Remarks | S Sale | 21,649 | $10.77 | $233,160 |
| Aug 24, 2026 | Kaiser Peter | Chief Development Officer | S Sale | 3,035 | $10.77 | $32,687 |
| Aug 24, 2026 | Heier Jeffrey S. | Chief Scientific Officer | S Sale | 3,296 | $10.78 | $35,531 |
| Aug 24, 2026 | Nayak Sanjay | Chief Strategy Officer | S Sale | 1,897 | $10.78 | $20,450 |
| Jun 16, 2026 | Dugel Pravin | See Remarks | G Gift | 50,092 | Not measured | Not measured |
| Jun 16, 2026 | Dugel Pravin | See Remarks | G Gift | 50,092 | Not measured | Not measured |
| Jun 10, 2026 | Williams Leslie J. | Director | A Award | 44,000 | Not measured | Not measured |
| Jun 10, 2026 | Warden Charles M | Director | A Award | 14,000 | Not measured | Not measured |
| Jun 10, 2026 | Williams Leslie J. | Director | A Award | 14,000 | Not measured | Not measured |
| Jun 10, 2026 | RAINES MERILEE | Director | A Award | 44,000 | Not measured | Not measured |
| Jun 10, 2026 | Robins Jason Shand | Chief Financial Officer | A Award | 15,441 | Not measured | Not measured |
| Jun 10, 2026 | Graves Adrienne L | Director | A Award | 14,000 | Not measured | Not measured |
| Jun 10, 2026 | Hong Seung Suh | Director | A Award | 44,000 | Not measured | Not measured |
| Jun 10, 2026 | Hong Seung Suh | Director | A Award | 14,000 | Not measured | Not measured |
| Jun 10, 2026 | RAINES MERILEE | Director | A Award | 14,000 | Not measured | Not measured |
| Jun 10, 2026 | Graves Adrienne L | Director | A Award | 44,000 | Not measured | Not measured |
| Jun 10, 2026 | LINDSTROM RICHARD L MD | Director | A Award | 14,000 | Not measured | Not measured |
| Jun 10, 2026 | Robins Jason Shand | Chief Financial Officer | A Award | 14,024 | Not measured | Not measured |
| Jun 10, 2026 | Warden Charles M | Director | A Award | 44,000 | Not measured | Not measured |
| Jun 10, 2026 | LINDSTROM RICHARD L MD | Director | A Award | 44,000 | Not measured | Not measured |
| Jun 3, 2026 | Waheed Nadia | Chief Medical Officer | S Sale | 14,828 | $8.27 | $122,628 |
| May 28, 2026 | Dugel Pravin | See Remarks | G Gift | 394,696 | Not measured | Not measured |
| May 28, 2026 | Dugel Pravin | See Remarks | G Gift | 394,696 | Not measured | Not measured |
| May 26, 2026 | Kaiser Peter | Chief Development Officer | S Sale | 2,967 | $8.20 | $24,329 |
| May 26, 2026 | Heier Jeffrey S. | Chief Scientific Officer | S Sale | 3,018 | $8.20 | $24,748 |
| May 26, 2026 | Nayak Sanjay | Chief Strategy Officer | S Sale | 1,858 | $8.20 | $15,236 |
| May 26, 2026 | Dugel Pravin | See Remarks | S Sale | 21,156 | $8.20 | $173,479 |
| Apr 9, 2026 | Dugel Pravin | See Remarks | G Gift | 394,696 | Not measured | Not measured |
| Apr 9, 2026 | Dugel Pravin | See Remarks | G Gift | 394,696 | Not measured | Not measured |
| Feb 23, 2026 | Nayak Sanjay | Chief Strategy Officer | S Sale | 1,759 | $8.28 | $14,565 |
| Feb 23, 2026 | Dugel Pravin | See Remarks | S Sale | 20,056 | $8.28 | $166,064 |
| Feb 23, 2026 | Kaiser Peter | Chief Development Officer | S Sale | 2,810 | $8.28 | $23,267 |
| Feb 23, 2026 | Heier Jeffrey S. | Chief Scientific Officer | S Sale | 3,057 | $8.28 | $25,312 |
| Feb 20, 2026 | Waheed Nadia | Chief Medical Officer | S Sale | 3,510 | $7.74 | $27,167 |
| Feb 20, 2026 | LINDSTROM RICHARD L MD | Director | P Purchase | 60,229 | $7.66 | $461,354 |
| Feb 12, 2026 | Waheed Nadia | Chief Medical Officer | S Sale | 7,863 | $9.04 | $71,082 |
| Feb 12, 2026 | Dugel Pravin | See Remarks | S Sale | 124,882 | $9.04 | $1,128,933 |
| Feb 12, 2026 | Notman Donald | Chief Operating Officer | S Sale | 11,446 | $9.04 | $103,472 |
| Feb 12, 2026 | Nayak Sanjay | Chief Strategy Officer | S Sale | 10,348 | $9.04 | $93,546 |
| Feb 4, 2026 | Notman Donald | Chief Operating Officer | S Sale | 6,035 | $8.54 | $51,539 |
| Feb 2, 2026 | Notman Donald | Chief Operating Officer | S Sale | 5,455 | $9.14 | $49,859 |
| Jan 21, 2026 | Robinson David Wayne | Global CCO | A Award | 416,000 | Not measured | Not measured |
| Jan 21, 2026 | Robinson David Wayne | Global CCO | A Award | 136,000 | Not measured | Not measured |
| Jan 20, 2026 | Robins Jason Shand | Chief Financial Officer | A Award | 33,000 | Not measured | Not measured |
The full Form 4 history is on the OCUL company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.